Pharma News

Want to avoid the debilitating knee pain? Keep moving, scientists suggest as they have found a mechanism that explains how motion can cause cartilage in the joints to reabsorb synovial fluid that leaks out in some conditions.

The Chinese government are trying out measures designed to provide better medical services for people with low income, a media report said on Monday.

Antibiotic use following surgery for complicated appendicitis may do more harm than good, suggests new research.

Opening the door for the development of new treatment of the lethal disease sepsis, scientists have identified a gene that triggers the inflammatory condition.

Prime Minister Narendra Modi on Sunday highlighted the need for organ donation in the country and encouraged people for it.

The number of opiate receptors in the brain, critical in the modulation of pain behaviour, increase to combat severe pain in arthritis sufferers, according to a study.

[adsense:336x280:8701650588]

Young adults with genetically-increased Alzheimer's risk have altered activation patterns in a brain region that is crucial for spatial navigation, a study has found.

Danish researchers have discovered a previously unknown function in histones -- responsible for packaging the DNA into structural units -- that will help improve understanding of how cells protect and repair DNA damage.

One stop diagnostics and patient management system "Healthcube Pro" capable of executing 32 tests at the same time was the showstopper at the fourth edition of Indian Pharma Expo 2015 which opened on Saturday.

The Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Novartis' Cosentyx (secukinumab) in Europe to treat ankylosing spondylitis (AS) and psoriatic arthritis (PsA) patients. Cosentyx is the first of a new class of medicines called interleukin-17A (IL-17A) inhibitors to be recommended for AS and PsA - conditions that affect around five million people in Europe.